Clincosm LogoSign in Get a demo

acute myeloid leukemia (aml)

Showing 26 - 50 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in China (Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Beijing, Beijing, China
  • +23 more
Aug 12, 2022

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • voruciclib monotherapy
  • voruciclib and venetoclax
  • Duarte, California
  • +10 more
Aug 10, 2022

Healthcare Resource Utilization in Adults Diagnosed With Acute

Completed
  • Acute Myeloid Leukemia (AML)
  • Helsinki, Finland
    Novartis Investigative Site
Aug 3, 2022

Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Jul 27, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia (AML)
  • Placebo
  • +2 more
  • Tampa, Florida
  • +108 more
Jul 15, 2022

Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Multiple Myeloma (MM)
  • 3x10(6) CART-38 cellls
  • +5 more
  • (no location specified)
Jul 15, 2022

Acute Myeloid Leukemia (AML), Cancer Trial in United States (venetoclax, azacytidine, decitabine)

Completed
  • Acute Myeloid Leukemia (AML)
  • Cancer
  • Tempe, Arizona
  • +15 more
Jun 10, 2022

Acute Myeloid Leukemia (AML) Trial in San Francisco (Niclosamide)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • San Francisco, California
    Stanford University
Jun 8, 2022

B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,

Not yet recruiting
  • B-Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 12, 2022

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

Acute Myeloid Leukemia (AML) Trial in Germany

Recruiting
  • Acute Myeloid Leukemia (AML)
    • Baden-Baden, Baden-Württemberg, Germany
    • +44 more
    Apr 4, 2022

    Variability in Biomarkers and PROs in AML

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Blood Sample Collection - Observational Study
    • Symptom questionnaires - Observational Study
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Apr 4, 2022

    Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

    Available
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • (no location specified)
    Mar 28, 2022

    Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

    Recruiting
    • Non-Hodgkin Lymphoma (NHL)
    • +2 more
    • Gent, Belgium
    • +9 more
    Mar 18, 2022

    Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)

    Terminated
    • Acute Myeloid Leukemia (AML)
    • Chicago, Illinois
    • +132 more
    Jan 24, 2022

    Acute Myeloid Leukemia (AML) Trial in Germany, United Kingdom, United States (Venetoclax, Alvocidib)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Los Angeles, California
    • +13 more
    Jan 24, 2022

    Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
      • Moscow, Moskva, Russian Federation
      • +9 more
      Jan 27, 2022

      Patterns and Key Healthcare Resource Use in Acute Myeloid

      Completed
      • Acute Myeloid Leukemia (AML)
      • Treatment patterns among AML patients
      • AML-related healthcare resources
      • Charlotte, North Carolina
        Sermo
      Jan 25, 2022

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • +2 more
      • Durham, North Carolina
        Duke University Health System
      Jan 10, 2022

      Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

      Active, not recruiting
      • Acute Lymphoid Leukemia (ALL)
      • +5 more
      • Hyperfractionated total body irradiation
      • +9 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 21, 2022

      Acute Myeloid Leukemia (AML) Trial in Germany (Cyclophosphamide (Non-IMP), Fludarabine (Non-IMP), TM123 (IMP))

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Cyclophosphamide (Non-IMP)
      • +3 more
      • Ulm, Baden-Württemberg, Germany
      • +5 more
      Dec 28, 2021

      Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • BP1001 in combination with Ventoclax plus decitabine
      • BP1001 plus decitabine
      • Fairway, Kansas
      • +5 more
      Jan 3, 2022

      Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Chengdu, Sichuan, China
        West China hospital of Sichuan University
      Nov 1, 2021

      Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

      Recruiting
      • Acute Lymphoblastic Leukemia (ALL)
      • +7 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Oct 8, 2021